Cargando…

Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration

PURPOSE: To compare the effect of adding a corticosteroid or switching to another anti-VEGF treatment in patients with exudative age-related macular degeneration (eAMD) with persisting intraretinal fluid on anti-VEGF monotherapy. METHODS: This retrospective, interventional case series involved 43 ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaya, Cagdas, Zandi, Souska, Pfister, Isabel B, Gerhardt, Christin, Garweg, Justus G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901048/ https://www.ncbi.nlm.nih.gov/pubmed/31824134 http://dx.doi.org/10.2147/OPTH.S224456

Ejemplares similares

Cytokine profiles in the aqueous humor and serum of patients with dry and treated wet age-related macular degeneration
por: Spindler, Jan, et al.
Publicado: (2018)

Visual Outcome after Intravitreal Anti-VEGF Therapy for Macular Neovascularisation Secondary to Sorsby’s Fundus Dystrophy: A Systematic Review
por: Baston, Arthur, et al.
Publicado: (2021)

Disease stability and extended dosing under anti-VEGF treatment of exudative age-related macular degeneration (AMD) — a meta-analysis
por: Garweg, Justus G., et al.
Publicado: (2021)

Comparison of cytokine profiles in the aqueous humor of eyes with pseudoexfoliation syndrome and glaucoma
por: Garweg, Justus G., et al.
Publicado: (2017)

Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus
por: Saucedo, Lucia, et al.
Publicado: (2021)

Risks and Challenges in Interpreting Simultaneous Analyses of Multiple Cytokines
por: Pfister, Isabel B., et al.
Publicado: (2020)

Continued anti-VEGF treatment does not prevent recurrences in eyes with stable neovascular age-related macular degeneration using a treat-and-extend regimen: a retrospective case series
por: Garweg, Justus G., et al.
Publicado: (2021)

Aqueous Humor Apolipoprotein Concentration and Severity of Diabetic Retinopathy in Type 2 Diabetes
por: Saucedo, Lucia, et al.
Publicado: (2022)

Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations
por: Zandi, Souska, et al.
Publicado: (2021)

Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment
por: Garweg, Justus G., et al.
Publicado: (2016)

Brolucizumab in Pretreated Neovascular Age-Related Macular Degeneration: Case Series, Systematic Review, and Meta-Analysis
por: Hänsli, Christof, et al.
Publicado: (2023)

Long-term outcomes of intravitreal therapy for symptomatic diabetic macular oedema in a real-world setting in Switzerland
por: Zirpel, Johanna J., et al.
Publicado: (2021)

Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment
por: Garweg, Justus G., et al.
Publicado: (2018)

Switching to Brolucizumab in Neovascular Age-Related Macular Degeneration Incompletely Responsive to Ranibizumab or Aflibercept: Real-Life 6 Month Outcomes
por: Haensli, Christof, et al.
Publicado: (2021)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
por: Garweg, Justus G
Publicado: (2019)

Psychological impact of anti-VEGF treatments for wet macular degeneration—a review
por: Senra, Hugo, et al.
Publicado: (2016)

Impact of Vitreal Tamponade on Functional Outcomes in Vitrectomy with ILM Peeling in Primary Macula-Involving Retinal Detachment: A Retrospective Analysis
por: Deiss, Mario, et al.
Publicado: (2020)

Biomarkers for PVR in rhegmatogenous retinal detachment
por: Zandi, Souska, et al.
Publicado: (2019)

Clinical and differential utility of VEGF inhibitors in wet age-related macular degeneration: focus on aflibercept
por: Stewart, Michael W
Publicado: (2012)

Imaging of Wet Age-Related Macular Degeneration
por: Kenan, Damer
Publicado: (2016)

Comparison of macular pigment optical density in patients with dry and wet age-related macular degeneration
por: Ozyurt, Ayhan, et al.
Publicado: (2017)

Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis
por: Ba, Jun, et al.
Publicado: (2015)

Intravitreal Dexamethasone in Patients with Wet Age-Related Macular Degeneration Resistant to Anti-VEGF: A Prospective Pilot Study
por: Giancipoli, Ermete, et al.
Publicado: (2018)

Pegaptanib in the treatment of wet, age-related macular degeneration
por: Vinores, Stanley A
Publicado: (2006)

Bevasiranib for the Treatment of Wet, Age-Related Macular Degeneration
por: Garba, Adinoyi O., et al.
Publicado: (2010)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
por: Chaikin, Laurie, et al.
Publicado: (2015)

Future Therapies of Wet Age-Related Macular Degeneration
por: Ishikawa, Makoto, et al.
Publicado: (2015)

Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
por: Garweg, Justus G., et al.
Publicado: (2023)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
por: García-Layana, Alfredo, et al.
Publicado: (2015)

Wet age related macular degeneration management and follow-up
por: Alexandru, Malciolu Radu, et al.
Publicado: (2016)

Hypertension affects the treatment of wet age‐related macular degeneration
por: Wang, Ting, et al.
Publicado: (2021)

Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis, Nikolaos, et al.
Publicado: (2016)

Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patients
por: Saucedo, Lucia, et al.
Publicado: (2023)

Functional Outcomes of Brolucizumab-Induced Intraocular Inflammation Involving the Posterior Segment—A Meta-Analysis and Systematic Review
por: Garweg, Justus G., et al.
Publicado: (2023)

Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
por: Bek, Toke, et al.
Publicado: (2018)

Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes
por: Wichrowska, Małgorzata, et al.
Publicado: (2022)

Functional Outcome After Macular Hole Surgery: Comparison of Standard Perimetry with Microperimetry
por: Wons, Juliana, et al.
Publicado: (2022)

Evaluation of circulating miRNAs in wet age-related macular degeneration
por: Ertekin, Sevda, et al.
Publicado: (2014)

Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles, Sadullah, et al.
Publicado: (2014)

Wide-Field Fluorescein Angiography in Wet Age-Related Macular Degeneration
por: Madhusudhan, Savitha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lmtuk36uelc2jb3mk9fvlq4b9v